Back

Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy

26 August 2018 (16:55 - 17:05)
Organised by:
Congress Presentation Part of: Cardiomyopathy in Fabry disease Infiltrative Myocardial Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Minako Kagimoto

Yokohama (Japan)

5 More presentations in this session

Presentation thumbnail
Hypertrophy of unaffected cardiomyocytes concurs to severity of cardiomyopathy in female patients with Fabry disease
Associate Professor C. Chimenti (Rome, IT)
Abstract
Presentation thumbnail
Speckle-tracking analysis of right ventricular function in Fabry disease - is left ventricle the only diseased chamber ?
Doctor J. Liao (Taipei, TW)
Abstract
Presentation thumbnail
Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers
Mr J. Muentze (Wuerzburg, DE)
Abstract
Presentation thumbnail
Cardiac magnetic resonance imaging in Fabry cardiomyopathy
Professor S. Moiseev (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Novel electrocardiographic parameters for the detection of Fabry Disease - A comparative multi-centre study
Doctor M. Namdar (Geneva, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathy in Fabry disease

The Event

Event poster

ESC Congress 2018

26 August 2018 16:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources